Huntington's disease (HD) is a movement disorder caused by a mutation in the Huntingtin gene that leads to severe neurodegeneration. Molecular...
Array
(
[id_prestablog_news] => 1883
[id_shop] => 1
[date] => 2023-08-14 00:00:00
[date_modification] => 2024-02-09 14:15:13
[langues] => ["1","2"]
[actif] => 1
[slide] => 0
[url_redirect] =>
[average_rating] =>
[number_rating] =>
[author_id] => 1
[featured] => 0
[prim_key] => 3425
[id_lang] => 1
[title] => Neuroprotective effects of hepatoma-derived growth factor in models of Huntingto
[paragraph] => Neuroprotective effects of hepatoma-derived growth factor in models of Huntington’s disease
[content] => Authors
Voelkl K, Gutiérrez-Ángel S, Keeling S, Koyuncu S, da Silva Padilha M, Feigenbutz D, Arzberger T, Vilchez D, Klein R, Dudanova I.
Lab
Max Planck Institute for Biological Intelligence, Martinsried, Germany
Journal
Life Sci Alliance
Abstract
Huntington's disease (HD) is a movement disorder caused by a mutation in the Huntingtin gene that leads to severe neurodegeneration. Molecular mechanisms of HD are not sufficiently understood, and no cure is currently available. Here, we demonstrate neuroprotective effects of hepatoma-derived growth factor (HDGF) in cellular and mouse HD models. We show that HD-vulnerable neurons in the striatum and cortex express lower levels of HDGF than resistant ones. Moreover, lack of endogenous HDGF exacerbated motor impairments and reduced the life span of R6/2 Huntington's disease mice. AAV-mediated delivery of HDGF into the brain reduced mutant Huntingtin inclusion load, but had no significant effect on motor behavior or life span. Interestingly, both nuclear and cytoplasmic versions of HDGF were efficient in rescuing mutant Huntingtin toxicity in cellular HD models. Moreover, extracellular application of recombinant HDGF improved viability of mutant Huntingtin-expressing primary neurons and reduced mutant Huntingtin aggregation in neural progenitor cells differentiated from human patient-derived induced pluripotent stem cells. Our findings provide new insights into the pathomechanisms of HD and demonstrate neuroprotective potential of HDGF in neurodegeneration.
BIOSEB Instruments Used
Grip strength test (BIO-GS4)
[meta_description] =>
[meta_keywords] => https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427761/
[meta_title] =>
[link_rewrite] => neuroprotective-effects-of-hepatoma-derived-growth-factor-in-models-of-huntingtons-disease
[actif_langue] => 1
[read] => 165
[count_comments] => 0
[id] => 1883
[categories] => Array
(
[47] => Array
(
[id_prestablog_categorie] => 47
[title] => Huntington's disease
[link_rewrite] => huntington-s-disease
)
[2] => Array
(
[id_prestablog_categorie] => 2
[title] => Publications
[link_rewrite] => publications
)
)
[authors] =>
[paragraph_crop] => Neuroprotective effects of hepatoma-derived growth factor in models of Huntington’s disease
[link_for_unique] => 1
[products_liaison] => Array
(
[48] => Array
(
[name] => Grip strength test
[description_short] => An easy way to objectively quantify the muscular strength of mice and rats, and to assess the effect of drugs, toxins, muscular (i.e. myopathy) and neurodegenerative diseases on muscular degeneration. It is widely used in conjunction with the ROTAROD motor coordination test: a normally coordinated rodent will show a decreased latency to fall off the rotating rod if its muscular strength is low. The Grip Strength Test is a must for your research on activity, motor control & coordination, and is particularly well suited for studies on Parkinson's & Huntington's disease.
New features GS4 - 2023: Color display with permanent backlight screen for easier reading, reset by footswitch, Improved battery time, Larger data memory of 500 values, Animal counter, USB port (charging/data transfer)


[thumb] =>
[img_empty] => /var/www/vhosts/de3310.ispfr.net/preprod.bioseb.com/modules/prestablog/views/img/product_link_white.jpg
[image_presente] => 1
[link] => https://preprod.bioseb.com/en/activity-motor-control-coordination/48-grip-strength-test.html
)
)
)
1 Read more